Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
5.25
+0.29 (5.85%)
Nov 18, 2026, 12:23 PM EST - Market open
Entrada Therapeutics Employees
Entrada Therapeutics had 152 employees as of December 31, 2025. The number of employees decreased by 31 or 16.94% compared to the previous year. That makes Entrada Therapeutics the 28,743rd largest employer in the world and 3,619th in the United States.
Employees
152
Change (1Y)
-31
Growth (1Y)
-16.94%
Revenue / Employee
$26,164
Profits / Employee
-$1,061,750
Market Cap
191.66M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 152 | -31 | -16.94% |
| Dec 31, 2024 | 183 | 24 | 15.09% |
| Sep 30, 2024 | 177 | 27 | 18.00% |
| Jun 30, 2024 | 168 | 37 | 28.24% |
| Mar 31, 2024 | 160 | 30 | 23.08% |
| Dec 31, 2023 | 159 | 29 | 22.31% |
| Sep 30, 2023 | 150 | 26 | 20.97% |
| Jun 30, 2023 | 131 | 9 | 7.38% |
| Mar 31, 2023 | 130 | 16 | 14.04% |
| Dec 31, 2022 | 130 | 16 | 14.04% |
| Sep 30, 2022 | 124 | 26 | 26.53% |
| Jun 30, 2022 | 122 | 44 | 56.41% |
| Mar 31, 2022 | 114 | 36 | 46.15% |
| Dec 31, 2021 | 114 | - | - |
| Sep 30, 2021 | 98 | - | - |
| Jun 30, 2021 | 78 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Artiva Biotherapeutics | 134 |
| MediWound | 121 |
| Cartesian Therapeutics | 75 |
| Compugen | 75 |
| Alpha Cognition | 71 |
| InflaRx | 65 |
| Korro Bio | 58 |
| Whitehawk Therapeutics | 37 |
TRDA News
- 4 hours ago - Entrada Therapeutics price target lowered to $13 from $17 at Guggenheim - TheFly
- 9 hours ago - Independent Safety Data Monitoring Committee Recommends Initiation of Cohort 3 at the Increased Dose of 15 mg/kg in Entrada Therapeutics' ELEVATE-45-201 Study - GlobeNewsWire
- 8 days ago - Entrada Therapeutics Transcript: 3rd Annual Guggenheim Healthcare Innovation Conference - Transcripts
- 12 days ago - Entrada Therapeutics price target lowered to $10 from $11 at Roth Capital - TheFly
- 13 days ago - Entrada Therapeutics reports Q3 EPS (94c), consensus (99c) - TheFly
- 13 days ago - Entrada Therapeutics Reports Third Quarter 2026 Financial Results - GlobeNewsWire
- 13 days ago - Entrada Therapeutics Quarterly report: Q3 2026 - Filings
- 13 days ago - Entrada Therapeutics Earnings release: Q3 2026 - Filings